HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeting the erythrocytic and liver stages of malaria parasites with s-triazine-based hybrids.

Abstract
A diversity-oriented library of s-triazine-based hybrids was screened for activity against the chloroquine-resistant Plasmodium falciparum W2 strain. The most striking result was sub-micromolar activity against cultured erythrocytic-stage parasites of hybrid molecules containing one or two 8-aminoquinoline moieties. These compounds were not clearly toxic to human cells. The most effective blood-schizontocidal s-triazine derivatives were then screened for activity against the liver stage of malaria parasites. The s-triazine hybrid containing two 8-aminoquinoline moieties and one chlorine atom emerged as the most potent against P. berghei liver-stage infection, active in the low nanomolar region, combined with good metabolic stability in rat liver microsomes. These results indicate that s-triazine-8-aminoquinoline-based hybrids are excellent starting points for lead optimization as dual-stage antimalarials.
AuthorsCatarina A B Rodrigues, Raquel F M Frade, Inês S Albuquerque, Maria J Perry, Jiri Gut, Marta Machado, Philip J Rosenthal, Miguel Prudêncio, Carlos A M Afonso, Rui Moreira
JournalChemMedChem (ChemMedChem) Vol. 10 Issue 5 Pg. 883-90 (May 2015) ISSN: 1860-7187 [Electronic] Germany
PMID25784585 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Chemical References
  • Antimalarials
  • Triazines
Topics
  • Animals
  • Antimalarials (chemistry, pharmacology)
  • CHO Cells
  • Cell Line, Tumor
  • Cell Proliferation
  • Cricetinae
  • Cricetulus
  • Dose-Response Relationship, Drug
  • Erythrocytes (parasitology)
  • Humans
  • Liver (parasitology)
  • Malaria (drug therapy, parasitology)
  • Parasitic Sensitivity Tests
  • Plasmodium berghei (drug effects)
  • Plasmodium falciparum (drug effects)
  • Rats
  • Structure-Activity Relationship
  • Triazines (chemistry, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: